Q3

Solara Active Pharma Sciences Ltd

SOLARAFY2524 Jan 2025

Revenue-13.4%

Net Profit+1.0%

OPM-14.81%

P&L

Quarterly Consolidated

Revenue

-13.4%300.31

Expenditure

-13.4%293.71

Net Profit

+1.0%8.09

NPM 2.68%+16.0%EPS ₹2.03-20.1%

vs Q2 FY25

Informational and educational content only. Not investment advice.